Literature DB >> 10834934

Co-localization of TFF3 peptide and oxytocin in the human hypothalamus.

W Jagla1, A Wiede, K Dietzmann, K Rutkowski, W Hoffmann.   

Abstract

TFF-peptides (formerly P domain peptides, trefoil factors) are typical secretory products of many mucous epithelial cells. TFF3 is also synthesized in the hypothalamus and has anxiolytic or anxiogenic activities when injected into the rat amygdala. Here we show by immunohistochemistry that TFF3 is localized to a distinct population of neurons of the human hypothalamic paraventricular and supraoptic nuclei. Generally, TFF3-positive cells are co-localized in oxytocin-producing cells and not in vasopressin-producing cells. Relatively large amounts of TFF3-but not TFF1 and TFF2-are present in the posterior lobe of the human pituitary, where it is probably released into the bloodstream. Furthermore, TFF3 was also detectable in human postmortem cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834934     DOI: 10.1096/fasebj.14.9.1126

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing.

Authors:  Ute Schulze; Ulrike Hampel; Saadettin Sel; Tamme W Goecke; Volker Thäle; Fabian Garreis; Friedrich Paulsen
Journal:  Histochem Cell Biol       Date:  2012-04-03       Impact factor: 4.304

2.  Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Authors:  Thaer Khoury; Krishdeep Chadha; Milind Javle; Kathleen Donohue; Charles Levea; Renuka Iyer; Haruhiko Okada; Hiroki Nagase; Dongfeng Tan
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Trefoil factor family peptides TFF1 and TFF3 in the nervous tissues of developing mouse embryo.

Authors:  Tatjana Belovari; Nikola Bijelić; Maja Tolušić Levak; Mirela Baus Lončar
Journal:  Bosn J Basic Med Sci       Date:  2015-02-01       Impact factor: 3.363

4.  TFF peptides and mucins are major components of dacryoliths.

Authors:  Friedrich P Paulsen; Ulrich Schaudig; Alexander Fabian; Dirk Ehrich; Saadettin Sel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

5.  Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma.

Authors:  Ponlatham Chaiyarit; Akasith Utrawichian; Chanvit Leelayuwat; Patrawut Vatanasapt; Nattharee Chanchareonsook; Mie Hessellund Samson; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2011-12-30       Impact factor: 3.573

Review 6.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

7.  PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3.

Authors:  Hai-Shui Shi; Wei-Li Zhu; Jian-Feng Liu; Yi-Xiao Luo; Ji-Jian Si; Shen-Jun Wang; Yan-Xue Xue; Zeng-Bo Ding; Jie Shi; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

8.  Effects of selegiline, a monoamine oxidase B inhibitor, on differentiation of P19 embryonal carcinoma stem cells, into neuron-like cells.

Authors:  Shabnam Bakhshalizadeh; Fariba Esmaeili; Fariba Houshmand; Hedayatollah Shirzad; Mojtaba Saedi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-08-20       Impact factor: 2.416

9.  Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.

Authors:  Qiang Li; Keke Wang; Chang Su; Jieyu Fang
Journal:  Technol Cancer Res Treat       Date:  2016-10-19

10.  Nuclear Factor Erythroid 2-Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen.

Authors:  Wenjuan Rui; Yuhong Zou; Joonyong Lee; Shashank Manohar Nambiar; Jingmei Lin; Linjie Zhang; Yan Yang; Guoli Dai
Journal:  J Pharmacol Exp Ther       Date:  2016-05-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.